<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03744039</url>
  </required_header>
  <id_info>
    <org_study_id>RCB : 2018-A01721-54</org_study_id>
    <nct_id>NCT03744039</nct_id>
  </id_info>
  <brief_title>Management of Diabetic Patients With Neuropathic Osteoarthropathy (Charcot Foot) : Descriptive Study in Diabetic-foot Centers</brief_title>
  <acronym>EPiChar</acronym>
  <official_title>Management of Diabetic Patients With Neuropathic Osteoarthropathy (Charcot Foot) : Descriptive Study in Diabetic-foot Centers.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite the prominence of diabetes prevalence (more than 8% of the world population in 2012)&#xD;
      and its expected increase in the next 15 years, Charcot foot remains a widely unknown&#xD;
      diabetes complication. At this day, there is no national guidelines about diagnosis and&#xD;
      treatment of this complication, which is known to alter life quality and to increase risk of&#xD;
      foot ulceration and mortality in diabetics. Through this descriptive multicentric study, we&#xD;
      will investigate the Charcot foot cares in diabetic-foot centers in France and Belgium.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">December 24, 2019</completion_date>
  <primary_completion_date type="Actual">December 24, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Charcot foot's diagnostic criteria</measure>
    <time_frame>inclusion visit</time_frame>
    <description>triggering factors : yes/no acute symptoms : : yes/no chronic symptoms : yes/no Presence of associated soft tissue infection : yes/no Presence of an associated bone infection : yes/no examinations performed to confirm the diagnosis of Charcot : yes/no</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Description Charcot foot's treatment</measure>
    <time_frame>inclusion visit</time_frame>
    <description>Discharge used in acute phase and/or in case of wound : yes/no Shoes used in chronic phase : yes/no</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Charcot foot</measure>
    <time_frame>inclusion visit</time_frame>
    <description>To determine diabetic patients' number with acute or chronic Charcot foot cared in diabetic-foot center in France and Belgium over a year (estimation of Charcot foot's incidence in diabetic-foot centers).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgery of Charcot foot</measure>
    <time_frame>inclusion visit</time_frame>
    <description>To identify which diabetic-foot centers propose surgical management in Charcot foot, to describe the type of surgery and the indications of surgical treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Register of Charcot foot</measure>
    <time_frame>inclusion visit</time_frame>
    <description>participation to a register of Charcot foot : yes/no</description>
  </secondary_outcome>
  <enrollment type="Actual">1160</enrollment>
  <condition>Diabetic Foot Neuroarthropathy Charcot</condition>
  <eligibility>
    <study_pop>
      <textblock>
        290-1160 consecutive patients with type 1 or type 2 diabetes mellitus and acute or chronic&#xD;
        osteo-neuroarthropathy in 29 diabetic-foot centers in France and Belgium (members of&#xD;
        workgroup &quot; diabetic foot &quot; in French-speaking Society of Diabetology)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patient has received written information about the study and did not oppose to&#xD;
             participate&#xD;
&#xD;
          -  The patient is affiliated to a health insurance programme&#xD;
&#xD;
          -  The patient is at least 18 years old&#xD;
&#xD;
          -  The patient is admitted to hospitalization or consultation&#xD;
&#xD;
          -  The patient is diagnosed with type 1 or type 2 diabetes mellitus&#xD;
&#xD;
          -  The patient is diagnosed with acute or chronic osteo-neuroarthropathy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The patient participates in another interventional study&#xD;
&#xD;
          -  The patient refuses to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU de Nîmes - Hôpital Universitaire de Réadaptation du Grau du Roi</name>
      <address>
        <city>Le Grau du Roi</city>
        <zip>30240</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nimes University Hospital</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>November 9, 2018</study_first_submitted>
  <study_first_submitted_qc>November 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2018</study_first_posted>
  <last_update_submitted>August 6, 2021</last_update_submitted>
  <last_update_submitted_qc>August 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Foot</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

